- Home
- VRE vs BBNX Comparison
VRE vs BBNX Comparison
Compare VRE & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VRE | BBNX |
|---|---|---|
| Founded | 1949 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 1994 | 2025 |
Fundamental Metrics
Financial Performance| Metric | VRE | BBNX |
|---|---|---|
| Price | $14.75 | $14.84 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 12 |
| Target Price | $18.67 | ★ $29.08 |
| AVG Volume (30 Days) | 592.8K | ★ 1.4M |
| Earning Date | 02-23-2026 | 02-17-2026 |
| Dividend Yield | ★ 2.14% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.68 | N/A |
| Revenue | ★ $291,348,000.00 | $88,570,000.00 |
| Revenue This Year | $4.85 | $53.58 |
| Revenue Next Year | N/A | $35.12 |
| P/E Ratio | $23.79 | ★ N/A |
| Revenue Growth | 6.39 | ★ 67.01 |
| 52 Week Low | $13.69 | $8.89 |
| 52 Week High | $17.18 | $32.71 |
Technical Indicators
Market Signals| Indicator | VRE | BBNX |
|---|---|---|
| Relative Strength Index (RSI) | 47.50 | 23.67 |
| Support Level | $14.61 | $14.46 |
| Resistance Level | $15.23 | $19.03 |
| Average True Range (ATR) | 0.32 | 1.65 |
| MACD | -0.01 | -0.59 |
| Stochastic Oscillator | 29.26 | 1.52 |
Price Performance
Historical ComparisonAbout VRE Veris Residential Inc.
Veris Residential Inc is a fully-integrated, self-administered and self-managed real estate investment trust (REIT). The company owns and operates a real estate portfolio comprised predominantly of multifamily rental properties located mainly in the Northeast and Class A office properties. The company performs substantially all real estate management, leasing, acquisition and development on an in-house basis. The properties are in three states in the Northeast, plus the District of Columbia. The company operates in two industry segments multifamily real estate & services and commercial & other real estate. The majority of revenue is from Multifamily real estate services.
About BBNX Beta Bionics Inc.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.